{"company":{"id":3783006,"name":"Alterome","domain":"alterome.com","url":"https://alion.io/company/world-16"},"section":"news","answer":"Alterome: 24 headlines on record, 5 headlines in the last 90 days. Its story counts 2 milestones.","figures":[{"label":"Headlines","value":"24"},{"label":"In 90 days","value":"5"},{"label":"Milestones","value":"2"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":15},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":2}],"news":[{"date":"2026-09-11","kind":"News","title":"Alterome Therapeutics Names Former Poseida CFO Johanna Mylet As Chief Financial Officer","source":"Pulse 2.0","url":"https://pulse2.com/alterome-therapeutics-names-former-poseida-cfo-johanna-mylet-as-chief-financial-officer/"},{"date":"2026-09-08","kind":"Blog","title":"Alterome Therapeutics Appoints Johanna Mylet as Chief Financial Officer","url":"https://alterome.com/alterome-therapeutics-appoints-johanna-mylet-as-chief-financial-officer/"},{"date":"2026-03-10","kind":"Blog","title":"Alterome Therapeutics to Participate in Upcoming Investor Conferences","url":"https://alterome.com/alterome-therapeutics-to-participate-in-upcoming-investor-conferences/"},{"date":"2026-02-02","kind":"Blog","title":"Alterome Therapeutics Appoints Leo Faoro, MD, MBA, as Chief Medical Officer","url":"https://alterome.com/alterome-therapeutics-appoints-leo-faoro-md-mba-as-chief-medical-officer/"},{"date":"2026-02-02","kind":"News","title":"PRN_FinancialWrapper","source":"PRNewswire","url":"https://markets.financialcontent.com/prnews.pre/article/bizwire-2026-2-2-alterome-therapeutics-appoints-leo-faoro-md-mba-as-chief-medical-officer"},{"date":"2025-09-22","kind":"Award","title":"Alterome Therapeutics, Inc. named one of Fierce Biotech's 2025 Fierce 15","url":"https://alterome.com/alterome-therapeutics-inc-named-one-of-fierce-biotechs-2025-fierce-15/"},{"date":"2025-04-10","kind":"Blog","title":"Alterome Therapeutics Announces New Chief Executive Officer and Chair of the Board of Directors","url":"https://alterome.com/alterome-therapeutics-announces-new-chief-executive-officer-and-chair-of-the-board-of-directors/"},{"date":"2025-03-10","kind":"Blog","title":"Alterome Doses First Patient in Phase 1 Study of ALTA3263, a Novel Pan-KRAS Dual ON/OFF Inhibitor, in Advanced Solid Tumors","url":"https://alterome.com/alterome-doses-first-patient-in-phase-1-study-of-alta3263-a-novel-pan-kras-dual-on-off-inhibitor-in-advanced-solid-tumors/"},{"date":"2025-01-15","kind":"Blog","title":"Imagenomix Corp. Partners with Alterome Therapeutics Inc. to Enhance Precision Oncology Clinical Trials with AI","url":"https://alterome.com/imagenomix-corp-partners-with-alterome-therapeutics-inc-to-enhance-precision-oncology-clinical-trials-with-ai/"},{"date":"2024-10-30","kind":"Blog","title":"Alterome Therapeutics Announces First Patient Dosed in Phase 1 Study of ALTA2618 in AKT1 E17K-mutant solid tumors (AKTive-001)","url":"https://alterome.com/alterome-therapeutics-announces-first-patient-dosed-in-phase-1-study-of-alta2618-in-akt1-e17k-mutant-solid-tumors-aktive-001/"},{"date":"2024-10-25","kind":"Blog","title":"Alterome Therapeutics to Present Preclinical Data for its KRAS Selective Inhibitor ALTA3263 at the 2024 ENA Symposium","url":"https://alterome.com/alterome-therapeutics-to-present-preclinical-data-for-its-kras-selective-inhibitor-alta3263-at-the-2024-ena-symposium/"},{"date":"2024-10-17","kind":"Award","title":"Eric Murphy, Ph.D., Co-Founder and CEO of Alterome, Named to Goldman Sachs Top 100 Most Exceptional Entrepreneurs at 2024 Builders and Innovators Summit","url":"https://alterome.com/eric-murphy-ph-d-co-founder-and-ceo-of-alterome-named-to-goldman-sachs-top-100-most-exceptional-entrepreneurs-at-2024-builders-and-innovators-summit/"},{"date":"2024-04-08","kind":"News","title":"Alterome Therapeutics: $132 Million Closed To Pioneer Small Molecule Targeted Therapies For Cancer Treatments","source":"Pulse 2.0","url":"https://pulse2.com/alterome-therapeutics-132-million-closed-to-pioneer-small-molecule-targeted-therapies-for-cancer-treatments/"},{"date":"2024-04-03","kind":"News","title":"Cancer biotech firm Alterome Therapeutics raises $132 mln in Goldman Sachs-led round","source":"YahooFinance","url":"https://finance.yahoo.com/news/cancer-biotech-firm-alterome-therapeutics-110511735.html"},{"date":"2024-04-03","kind":"Press release","title":"Alterome Therapeutics Raises $132 Million in Series B Financing Led by Goldman Sachs Alternatives","source":"Nasdaq","url":"https://nasdaq.com/press-release/alterome-therapeutics-raises-$132-million-in-series-b-financing-led-by-goldman-sachs"}],"story":[{"title":"Raised a round Venture round $63.8M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1904936/000190493622000001/"},{"title":"Founded"}],"as_of":"2026-11-17","cite":"Alterome, News. Alion, Nov 17, 2026. https://alion.io/company/world-16/news","html_url":"https://alion.io/company/world-16/news","json_url":"https://alion.io/company/world-16/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-17T21:47:36Z"}}